| To assess the frequency of sensitization to topical treatment of AD in children and to determine risk factors associated with skin sensitization. Methods: Six hundred and forty-one children with AD were systematically patch tested with seven agents of common topical treatment: chlorhexidine, hexamidine, budesonide, tixocortol pivalate, bufexamac, sodium fusidate and with the current emollient used by the child | |